Stockreport

Taysha Gene Therapies Provides Update on Deprioritized Pipeline Programs

Taysha Gene Therapies, Inc.  (TSHA) 
PDF DALLAS, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (“Taysha” or “the Company”), a clinical-stage gene therapy company focused on deve [Read more]